Dr Otto Schwarz is a highly accomplished industry executive bringing 35 years of experience to Arvelle, having launched multiple major speciality products on a global basis. Most recently, Otto served as Executive Vice-President, Chief Operating Officer and a member of the Actelion Executive Committee, until the acquisition of Actelion by Johnson & Johnson. During his time at Actelion, Otto was responsible for 1300 employees, leading global operation activities including marketing strategy & sales, medical affairs, manufacturing and supply chain. Under Otto’s leadership, Actelion successfully launched specialty products Opsumit, Uptravi and Veletri, increasing total company sales to over CHF 2.4 billion by 2016, its last year as an independent company. Prior to Actelion, Otto also served as Executive Vice-President Commercial Operations at Nycomed, and Executive Board Member at Altana Pharma. He also spent nearly 20 years with Schering-Plough and Eli Lilly in Switzerland, Canada, the USA and Germany. Dr Otto Schwarz currently also serves as a non-Executive Director of Kiadis Pharma. Dr Otto Schwarz is an Austrian citizen and has a PhD in pharmaceutical chemistry from Vienna University.